Literature DB >> 26869001

Clarifying Assumptions and Outcomes in Cost-effectiveness Analyses.

Kevin ten Haaf1, Harry J de Koning1.   

Abstract

Entities:  

Mesh：

Year:  2016        PMID： 26869001      PMCID： PMC4978811          DOI： 10.1001/jamaoncol.2015.4457

Source DB:  PubMed          Journal:  JAMA Oncol        ISSN： 2374-2437            Impact factor:   31.777


× No keyword cloud information.
  5 in total

1.  Overdiagnosis in lung cancer screening: why modelling is essential.

Authors:  Kevin Ten Haaf; Harry J de Koning
Journal:  J Epidemiol Community Health       Date:  2015-06-12       Impact factor: 3.710

2.  50-year trends in smoking-related mortality in the United States.

Authors:  Michael J Thun; Brian D Carter; Diane Feskanich; Neal D Freedman; Ross Prentice; Alan D Lopez; Patricia Hartge; Susan M Gapstur
Journal:  N Engl J Med       Date:  2013-01-24       Impact factor: 91.245

3.  Cost-effectiveness of Lung Cancer Screening in Canada.

Authors:  John R Goffin; William M Flanagan; Anthony B Miller; Natalie R Fitzgerald; Saima Memon; Michael C Wolfson; William K Evans
Journal:  JAMA Oncol       Date:  2015-09       Impact factor: 31.777

4.  US norms for six generic health-related quality-of-life indexes from the National Health Measurement study.

Authors:  Dennis G Fryback; Nancy Cross Dunham; Mari Palta; Janel Hanmer; Jennifer Buechner; Dasha Cherepanov; Shani A Herrington; Ron D Hays; Robert M Kaplan; Theodore G Ganiats; David Feeny; Paul Kind
Journal:  Med Care       Date:  2007-12       Impact factor: 2.983

5.  Benefits and harms of computed tomography lung cancer screening strategies: a comparative modeling study for the U.S. Preventive Services Task Force.

Authors:  Harry J de Koning; Rafael Meza; Sylvia K Plevritis; Kevin ten Haaf; Vidit N Munshi; Jihyoun Jeon; Saadet Ayca Erdogan; Chung Yin Kong; Summer S Han; Joost van Rosmalen; Sung Eun Choi; Paul F Pinsky; Amy Berrington de Gonzalez; Christine D Berg; William C Black; Martin C Tammemägi; William D Hazelton; Eric J Feuer; Pamela M McMahon
Journal:  Ann Intern Med       Date:  2014-03-04       Impact factor: 25.391
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.